Timothy Clyne on the COMFORT Curriculum and End-of-Life Discussions

Video
Conferences|ONS Annual Congress

Timothy Clyne, RN, Trinitas Regional Medical Center, discusses the COMFORT curriculum and end-of-life conversations.

Timothy Clyne, RN, Trinitas Regional Medical Center, discusses the COMFORT curriculum and end-of-life conversations.

Before implementing the COMFORT curriculum, an educational model that helps oncology nurses navigate discussions regarding palliative care developed at City of Hope, he conducted a pre-assesment of the nursing assistants and nurses to see where they stand when it comes to end-of-life discussions with their patients. He found that many of them, especially those who were younger or less experienced, felt uncomfortable with having these type of talks with their patients.

Recent Videos
Related Content
doctor in white coat holding hand out with the word "immunotherapy" floating above

Novel Drug Combo Is Promising for PD-L1-Resistant Solid Cancers

Russ Conroy
November 12th 2024
Article

Adding E-602 to cemiplimab demonstrated anti-tumor effects in patients PD-L1–resistant solid cancers.

The Vitals

Lauren Mahon Offers Nurse Perspectives on PARP Inhibitors As Ovarian Cancer Maintenance Therapy

Lindsay Fischer
June 15th 2023
Podcast

Lauren Mahon, MSN, FNP-BC, breaks down what oncology nurses should know about PARP inhibitors in ovarian cancer.

gynecologic cancer

Novel ADC Shows Promise in Platinum-Resistant Ovarian Cancer

Ryan Scott
November 5th 2024
Article

The novel drug SHR-A1921 was safe and efficacious in patients with platinum-resistant ovarian cancer, according to phase 1 data.

The Vitals

Seth Eisenberg Discusses New Methods of Reducing Hazardous Drug–Contaminated Toilet Aerosols in Hospital Setting

Lindsay Fischer
June 1st 2023
Podcast

Seth Eisenberg, ASN, RN, OCN, BMTCN, emphasizes the importance of reducing nurse exposure to hazardous drugs—and ongoing research efforts to improve nursing safety.

cells

NT-I7 Enhances CAR T-Cell Efficacy in DLBCL

Jax DiEugenio
October 11th 2024
Article

NT-17, a long-acting IL-7 agent, enhances CAR T-cell factors associated with efficacy in patients with relapsed/refractory DLBCL when administered 21 days post-CAR T infusion.

gastric system with stethoscope around it

Non-Operative Management of Rectal Cancer Does Not Worsen Distant RFS

Ariana Pelosci
September 25th 2024
Article

Distant relapse-free survival was maintained with non-operative management of pMMR locally advanced rectal cancer.

© 2024 MJH Life Sciences

All rights reserved.